文献速递腹部MR

胰腺导管腺癌:MR成像边缘强化预测根治性切除后的预后

Pancreatic Ductal Adenocarcinoma: Rim Enhancement at MR Imaging Predicts Prognosis after Curative Resection.
PubMed 文献 · Radiology · 2018-04-17

回顾性纳入2009年1月至2014年12月143例R0切除的胰腺导管腺癌患者,术前1个月内行MR成像,用Cox模型分析无病生存和总生存的预测因素。肿瘤大小和边缘强化与更差的无病生存和总生存相关,扩散加权成像参数未预测生存。

要点

  • 术前MR动态增强边缘强化提示胰腺导管腺癌根治性切除后无病生存和总生存更差。
  • 肿瘤病理大小每增加1 cm,无病生存和总生存风险分别增加(HR 1.37和1.44)。
  • 扩散加权成像的扩散受限和ADC值未预测根治性切除后的无病生存或总生存。

核心结论

  • 肿瘤较大和边缘强化与胰腺导管腺癌尝试根治性切除后较低的无病生存率和总生存率相关。

研究设计与样本

  • 回顾性研究,纳入2009年1月至2014年12月143例手术切除(R0)的胰腺导管腺癌患者,术前1个月内行MR成像。
  • 采用Cox比例风险模型识别预测无病生存和总生存的临床病理及MR成像因素,并将重要MR成像特征与临床病理发现进行比较。

关键影像表现/征象

  • 动态增强MR成像上边缘强化与显著更差的无病生存(HR 1.72;95%CI:1.05,2.82;P=.030)和总生存(HR 2.27;95%CI:1.39,3.69;P=.001)相关。
  • 边缘强化病灶较无边缘强化的胰腺病灶具有更侵袭性的组织学肿瘤分级(P=.002)、残留腺泡更少(P=.008)和瘤内坏死更频繁(P<.001)。

诊断标准与关键数值

  • 病理肿瘤大小与无病生存相关(每厘米HR 1.37;95%CI:1.15,1.63;P<.001)和总生存相关(HR 1.44;95%CI:1.20,1.73;P<.001)。
  • 扩散加权成像参数包括扩散受限和表观扩散系数值未预测胰腺导管腺癌切除后的无病生存或总生存(所有P>.05)。

临床应用与阅片要点

  • 术前MR动态增强发现边缘强化时,可提示胰腺导管腺癌根治性切除后无病生存和总生存更差。
  • 评估肿瘤大小和边缘强化有助于术前预后分层。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Purpose To identify features at preoperative magnetic resonance (MR) imaging that could predict favorable prognosis after curative resection of pancreatic ductal adenocarcinoma (PDAC). Materials and Methods From January 2009 to December 2014, this retrospective study included 143 patients with surgically resected (ie, R0) PDAC who underwent preoperative MR imaging within 1 month before surgery. Clinical-pathologic and MR imaging findings for predicting disease-free survival (DFS) and overall survival (OS) were identified by using a Cox proportional hazards model. Important MR imaging features were compared with clinical-pathologic findings. Results Tumor size at histopathologic analysis was associated with both DFS and OS (hazard ratio per centimeter, 1.37; 95% confidence interval: 1.15, 1.63; P < .001 and hazard ratio, 1.44; 95% confidence interval: 1.20, 1.73; P < .001, respectively). Rim enhancement at dynamic contrast material-enhanced MR imaging was associated with significantly worse DFS and OS (hazard ratio, 1.72; 95% confidence interval: 1.05, 2.82; P = .030 and hazard ratio, 2.27; 95% confidence interval: 1.39, 3.69; P = .001, respectively). Diffusion-weighted imaging parameters, including diffusion restriction and apparent diffusion coefficient value, did not predict DFS or OS after resection of PDAC (all P > .05). Rim-enhancing lesions had more aggressive histologic tumor grades, less frequent remaining acini, and more frequent necrosis within the tumor compared with non-rim-enhancing pancreatic lesions (P = .002, P = .008, and P < .001, respectively). Conclusion Greater tumor size and rim enhancement were associated with lower DFS and OS rates after attempted curative resection of PDAC.

来源:Radiology,查看原文。版权归原作者所有。

引用

  1. Lee S, Kim SH, Park HK, et al. Pancreatic Ductal Adenocarcinoma: Rim Enhancement at MR Imaging Predicts Prognosis after Curative Resection. Radiology. 2018. PMID: 29664340. doi:10.1148/radiol.2018172331

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。